Brucke Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
4,307
+8
+0.2% +$2.11K 0.48% 40
2026
Q2
$1.09M Buy
4,299
+98
+2% +$22.8K 0.49% 39
2026
Q1
$1.03M Buy
4,201
+741
+21% +$173K 0.52% 38
2025
Q4
$716K Buy
3,460
+60
+2% +$11.9K 0.39% 57
2025
Q3
$642K Sell
3,400
-1,510
-31% -$259K 0.38% 53
2025
Q2
$750K Sell
4,910
-316
-6% -$48.6K 0.52% 41
2025
Q1
$817K Sell
5,226
-116
-2% -$18.2K 0.71% 33
2024
Q4
$813K Buy
+5,342
New +$828K 0.7% 32

Other funds holding JNJ

Brucke Financial's JNJ Position: Q3 2026 in Review

Brucke Financial increased its Johnson & Johnson (JNJ) stake by 0.19% in Q3 2026, buying an estimated $2.11K and bringing the position to 4,307 shares worth $1.14M. The position accounts for 0.48% of the portfolio, ranked #40.

Brucke Financial first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 3,914 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Brucke Financial held 4,307 shares of Johnson & Johnson worth $1.14M as of Q3 2026.
  • Brucke Financial bought 8 Johnson & Johnson shares in Q3 2026, an estimated $2.11K.
  • Johnson & Johnson made up 0.48% of Brucke Financial's portfolio in Q3 2026, its #40 holding.
  • Brucke Financial first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 3,914 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Brucke Financial's 13F filing for Q3 2026, filed 23 Oct 2026.